Published in Level 2 journals, first or last author from Oslo University Hospital.
NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer
Gynecol Oncol, 199, 79-87 (in press)
DOI 10.1016/j.ygyno.2025.06.008, PubMed 40592025
Self-reported symptoms in ICU patients and their impact on long-term outcomes-a prospective multicenter study
Intensive Care Med (in press)
DOI 10.1007/s00134-025-07995-x, PubMed 40586802
High dose arachidonic and docosahexaenoic acid in very preterm infants and neurodevelopment at 2 years - A double-blind randomized controlled trial
Clin Nutr, 51, 198-205 (in press)
DOI 10.1016/j.clnu.2025.05.019, PubMed 40580806